Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register.
Steinunn ArnardóttirJacob JäråsPia BurmanKatarina BerinderPer DahlqvistEva Marie ErfurthCharlotte HöybyeKarin LarssonOskar RagnarssonBertil EkmanBritt Edén EngströmPublished in: European journal of endocrinology (2022)
The proportion of patients with biochemical control increased over time. Patients with biochemically controlled acromegaly have normal life expectancy, while non-controlled patients still have increased mortality. The high rate of macroadenomas and unchanged age at diagnosis illustrates the need for improvements in the management of patients with acromegaly.